Who Owns Carelon?
Carelon is owned by Elevance Health, Inc. (NYSE: ELV), a publicly traded health insurance company headquartered in Indianapolis, Indiana. Carelon operates as Elevance's health services subsidiary, administering behavioral health benefits, medical benefit management, and payment integrity programs. The division serves over 1 million patients through New York's Empire Plan alone. In March 2026, a federal judge allowed a class action lawsuit alleging Carelon maintained ghost provider networks to proceed.
Parent Company
Elevance Health Inc.
Founded
2022
Status
Publicly Traded
Headquarters
Indianapolis, Indiana, USA
Who Owns Carelon?
- Parent Company: Elevance Health Inc.
- Ownership Type: Subsidiary
- Company Type: Publicly Traded
- Stock Ticker: NYSE: ELV
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Carelon | Elevance Health Inc. | Subsidiary |
History of Carelon
- Founded: 2022
- Founders: Elevance Health
Carelon's origins trace back to several acquisitions and business lines that Elevance Health (then Anthem) assembled over more than a decade. The division's largest component, Carelon Behavioral Health, descends from Beacon Health Options, a behavioral health management company that Anthem acquired in 2020.
Beacon Health Options was itself the product of a 2014 merger between Beacon Health Strategies and ValueOptions, two behavioral health management organizations. Before Anthem's acquisition, Beacon served over 40 million members across 50 states and managed behavioral health benefits for state Medicaid programs, federal employees, and commercial health plans.
Anthem acquired Beacon Health Options in 2020 to strengthen its behavioral health capabilities. The acquisition brought expertise in managing mental health and substance use disorder benefits, an area of growing demand. At the time, Anthem was already one of the largest Blue Cross Blue Shield operators, and adding Beacon's behavioral health infrastructure allowed the company to offer more integrated care management.
In June 2022, Anthem rebranded as Elevance Health and announced the creation of Carelon as its health services brand. The Carelon brand unified several existing business lines under a single identity. Carelon Behavioral Health replaced the Beacon Health Options name. Carelon Medical Benefits Management consolidated Anthem's radiology, cardiology, and specialty drug management services. Carelon Payment Integrity brought together claims payment and fraud detection operations.
The rebranding reflected a strategic shift at Elevance Health. The company wanted to position itself as more than an insurance provider. By creating Carelon as a distinct brand, Elevance Health signaled its intention to grow its health services business both internally and externally. Carelon could sell its services to other health plans and employers, not just to Elevance Health's own insurance operations.
Carelon Behavioral Health administers mental health and substance use disorder benefits for health plans and employers. The company contracts with states to manage behavioral health benefits for public employees. Its largest single contract is with the New York State Health Insurance Program (NYSHIP), where it administers mental health benefits for the Empire Plan. This contract is valued at more than $2.7 billion and runs through the end of 2028.
Carelon Medical Benefits Management provides prior authorization and clinical review services for high-cost medical procedures. This includes radiology management (ensuring appropriate use of imaging services), cardiology management, and specialty drug management. These services help health plans control costs by reviewing whether requested procedures are medically necessary.
Carelon Payment Integrity focuses on detecting and preventing improper payments in healthcare claims. The division uses data analytics to identify billing errors, duplicate claims, and potential fraud. This service is offered to both Elevance Health's insurance plans and to external clients.
About Elevance Health Inc.
Elevance Health operates through several key business segments focused on health benefits and services. The company provides health insurance products to individuals, employers, and government programs including Medicare and Medicaid.
The Health Benefits segment includes medical, pharmacy, behavioral health, and dental insurance products. Elevance Health serves millions of members through its Blue Cross Blue Shield plans in 14 states and through its Anthem brand in other markets.
Elevance Health has also developed an integrated care delivery system through its Carelon subsidiaries. Carelon provides pharmacy benefits management, behavioral health services, care management, and other health services that complement the company's insurance offerings.
The company has invested heavily in digital health platforms and data analytics to improve care coordination and health outcomes. Elevance Health's whole health approach focuses on addressing social determinants of health and providing comprehensive care solutions.
Elevance Health employs approximately 104,000 people and generates annual revenues exceeding $140 billion. The company serves millions of members across the United States and maintains significant market positions in commercial, Medicare, and Medicaid markets.
- Founded: 1946
- Headquarters: Indianapolis, Indiana, USA
- Company Type: Publicly Traded
- Stock: NYSE: ELV
- Revenue: approximately $174.9 billion (FY2024)
- Employees: Approximately 100,000
Where Is Carelon Made / Based?
- Headquarters: Indianapolis, Indiana, USA
Carelon Sustainability & Ethics
Carelon does not hold independently verified sustainability certifications from recognized third-party organizations. The standard certifications tracked in consumer goods, such as cruelty-free, vegan, or B Corp, do not apply to a B2B healthcare services business.
Elevance Health publishes corporate responsibility reports covering environmental, social, and governance practices. The company has set goals for reducing its carbon footprint and improving health equity. These corporate-level commitments apply to Carelon as a subsidiary.
In terms of social impact, Carelon's behavioral health administration services affect millions of patients. The quality of these services, including the accuracy of provider directories and the timeliness of prior authorization decisions, directly affects patient access to mental health care. The ghost network lawsuit alleges that Carelon's practices have harmed patients by making it difficult to find in-network mental health providers.
Awards & Recognition
Carelon as a brand has not been the subject of major independent industry awards as of August 2026. The division was created in 2022 and is still establishing its independent brand identity separate from Elevance Health.
Elevance Health has received recognition for its corporate practices, including inclusion in the Dow Jones Sustainability Index and recognition from the Human Rights Campaign for LGBTQ+ workplace equality. These recognitions apply to the parent company rather than to Carelon specifically.
Carelon Recalls & Controversies
Carelon Behavioral Health is the defendant in a class action lawsuit alleging the company maintained ghost provider networks for mental health services. The lawsuit, filed in April 2025 in the Southern District of New York (case 25-cv-03489), accuses Carelon of publishing inaccurate provider directories for the Empire Plan in the New York State Health Insurance Program.
Three plaintiffs filed the suit on behalf of more than 1 million Carelon patients enrolled in the Empire Plan. The plaintiffs allege that Carelon's provider directory listed mental health providers who were not actually in-network, not accepting new patients, or could not be reached at listed contact information. A secret shopper survey conducted by the plaintiffs' attorneys called 300 providers listed in Carelon's directory. Only 17% of those providers accepted the coverage and were taking new patients.
On March 31, 2026, Judge Edgardo Ramos denied Carelon's motion to dismiss the case. The judge dismissed breach of contract claims, finding that Carelon's contract was with New York State rather than with individual members. However, the judge allowed claims for deceptive business practices, deceptive advertising, fraudulent and negligent misrepresentation, and unjust enrichment to proceed.
The New York Attorney General's office has also investigated ghost networks. A study by the OAG found that 86% of mental health providers listed on health plans' networks were effectively ghosts. The U.S. Senate Finance Committee conducted a similar survey and found that, on average, 82% of directory listings were ineffective.
A separate lawsuit filed in October 2024 by federal employees with Anthem BCBS coverage alleged similar ghost network issues. That case was dismissed in March 2026 after the judge ruled that federal law governed the dispute, blocking state-law claims.
The ghost network lawsuit is the most significant controversy facing Carelon as of August 2026. The case could result in monetary damages and injunctive relief if the plaintiffs prevail. It also draws attention to broader industry issues with provider directory accuracy and mental health access.
Brands Owned by Elevance Health Inc.
- Anthem Blue Cross - Health insurance brand providing medical, pharmacy, behavioral, and dental cover...
- Anthem Blue Shield - Health insurance brand providing medical, pharmacy, behavioral, and dental cover...
- WellPoint - Elevance Health's government health plan brand for Medicaid, CHIP, and Medicare ...
Sources & Further Reading
- [Elevance Health 'Ghost Network' Case Moves Forward, Fierce Healthcare](
- [Court Allows Key Claims in Ghost Network Case, Pollock Cohen LLP](
- [Elevance Mental Health Ghost Network Lawsuit, Becker's Payer Issues](
- [Lawsuit Against Elevance Health, Health Exec](
- [Elevance Health Investor Relations](
- [Carelon Website](
- [Court Filing: 25-cv-03489, Southern District of New York](
Where to Buy
Disclosure: We may earn commission from purchasesCompetitors to Carelon
No direct competitors found in the same category. This could be because Carelonoperates in a unique market segment or we're still building our competitor database.
Elevance Health Inc. Stock Information
Jobs at Elevance Health Inc.
Latest News About Carelon
Related Articles About Carelon
View more articlesMonthly IPO Roundup: August 2026 — July's Biggest Listings
July 2026 IPOs: CXMT raised $8.6B in China's biggest semiconductor IPO ever, Jersey Mike's priced a $1B NYSE debut, Csquare raised $1.05B for data centers, Reformation went public at $886M, and Scribe Therapeutics became the first gene editing IPO in two years. Full recap.
Monthly M&A Roundup: July 2026 Brand Ownership Changes
July 2026's biggest deals: Stripe and Advent bid $53B for PayPal, Vertex acquired Crinetics for $10B, Couche-Tard bought Żabka for $8.6B, Utz went private in a $2.9B deal with Intersnack, and Kroger acquired Giant Eagle for $1.65B. Full breakdown.
Monthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Accutane
Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase
Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.

Acuvue
Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.